The Akt downregulates Treg cells while upregulates CD4+ and CD8+ tumor-infiltrating lymphocytes (TILs), leading to IFNγ expression and thereby inducing an anti-tumor immune response [268]. The gene discussed is AKT1; the disease is neoplasm.